These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22980216)

  • 1. Liver perfusion CT during hepatic arteriography for the hepatocellular carcinoma: dose reduction and quantitative evaluation for normal- and ultralow-dose protocol.
    Watanabe S; Katada Y; Gohkyu M; Nakajima M; Kawabata H; Nozaki M
    Eur J Radiol; 2012 Dec; 81(12):3993-7. PubMed ID: 22980216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
    Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic blood volume imaging with the use of flat-detector CT perfusion in the angiography suite: comparison with results of conventional multislice CT perfusion.
    Zhuang ZG; Zhang XB; Han JF; Beilner J; Deuerling-Zheng Y; Chi JC; Wang J; Qian LJ; Zhou Y; Xu JR
    J Vasc Interv Radiol; 2014 May; 25(5):739-46. PubMed ID: 24745904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic CT perfusion measurements: a feasibility study for radiation dose reduction using new image reconstruction method.
    Negi N; Yoshikawa T; Ohno Y; Somiya Y; Sekitani T; Sugihara N; Koyama H; Kanda T; Kanata N; Murakami T; Kawamitsu H; Sugimura K
    Eur J Radiol; 2012 Nov; 81(11):3048-54. PubMed ID: 22613507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can low-dose CT with iterative reconstruction reduce both the radiation dose and the amount of iodine contrast medium in a dynamic CT study of the liver?
    Takahashi H; Okada M; Hyodo T; Hidaka S; Kagawa Y; Matsuki M; Tsurusaki M; Murakami T
    Eur J Radiol; 2014 Apr; 83(4):684-91. PubMed ID: 24418284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative dual energy CT measurements in rabbit VX2 liver tumors: Comparison to perfusion CT measurements and histopathological findings.
    Zhang LJ; Wu S; Wang M; Lu L; Chen B; Jin L; Wang J; Larson AC; Lu GM
    Eur J Radiol; 2012 Aug; 81(8):1766-75. PubMed ID: 21835570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV; Holalkere NS; Mueller PR; Zhu AX
    Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.).
    Okada M; Kim T; Murakami T
    Abdom Imaging; 2011 Jun; 36(3):273-81. PubMed ID: 21267563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractal analysis of CT perfusion images for evaluation of antiangiogenic treatment and survival in hepatocellular carcinoma.
    Hayano K; Lee SH; Yoshida H; Zhu AX; Sahani DV
    Acad Radiol; 2014 May; 21(5):654-60. PubMed ID: 24703479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual comparison of diagnostic performance in patients with hepatic metastasis of full-dose standard and half-dose iterative reconstructions with dual-source abdominal computed tomography.
    Park M; Chung YE; Lee HS; Choi JY; Park MS; Kim MJ; Kim KW
    Invest Radiol; 2014 Apr; 49(4):195-200. PubMed ID: 24300843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.
    Goetti R; Leschka S; Desbiolles L; Klotz E; Samaras P; von Boehmer L; Stenner F; Reiner C; Stolzmann P; Scheffel H; Knuth A; Marincek B; Alkadhi H
    Invest Radiol; 2010 Jul; 45(7):419-26. PubMed ID: 20498611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study.
    Sacco R; Faggioni L; Bargellini I; Ginanni B; Battaglia V; Romano A; Bertini M; Bresci G; Bartolozzi C
    Dig Liver Dis; 2013 Sep; 45(9):776-81. PubMed ID: 23578581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation.
    Kitao A; Zen Y; Matsui O; Gabata T; Nakanuma Y
    Radiology; 2009 Aug; 252(2):605-14. PubMed ID: 19703890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose hepatic computed tomography perfusion imaging and its preliminary study.
    Wang WJ; Zhong L; Hua XL; Fan Y; Li L; Xu JR
    J Dig Dis; 2011 Jun; 12(3):204-9. PubMed ID: 21615875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model.
    Choi SH; Chung JW; Kim HC; Baek JH; Park CM; Jun S; Kim MU; Lee ES; Cho HR; Jae HJ; Lee W; Park JH
    Invest Radiol; 2010 Jul; 45(7):427-36. PubMed ID: 20440211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography.
    Pugacheva O; Matsui O; Kozaka K; Minami T; Ryu Y; Koda W; Kobayashi S; Gabata T
    Eur J Radiol; 2011 Dec; 80(3):e201-6. PubMed ID: 20855175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT perfusion of the liver during selective hepatic arteriography: pure arterial blood perfusion of liver tumor and parenchyma.
    Komemushi A; Tanigawa N; Kojima H; Kariya S; Sawada S
    Radiat Med; 2003; 21(6):246-51. PubMed ID: 14743897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma.
    Ippolito D; Fior D; Franzesi CT; Capraro C; Casiraghi A; Leni D; Vacirca F; Corso R; Sironi S
    Dig Liver Dis; 2014 Oct; 46(10):916-22. PubMed ID: 25023006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.